Investors

Date	Name	Title	Type	Shares Traded	Price Range
Feb 14, 2011	terifay robert j	Officer	Option Execute	5,000	21.34
Feb 17, 2011	terifay robert j	Officer	Option Execute	48,901	21.34 - 21.92
Mar 4, 2011	terifay robert j	Officer	Option Execute	6,099	21.92
May 6, 2013	tessier-lavigne marc	Director	Option Execute	13,334	50.91 - 57.11
Feb 27, 2008	vagelos p roy	Director	Option Execute	6,666	7.91
Dec 19, 2008	vagelos p roy	Director	Option Execute	130,000	7.41
Dec 8, 2009	vagelos p roy	Director	Option Execute	187,500	8.77
Aug 31, 2011	vagelos p roy	Officer	Option Execute	312,500	28.01
Nov 23, 2012	vagelos p roy	Officer	Option Execute	312,500	19.43
Dec 20, 2012	van plew daniel p	Officer	Option Execute	2,050	16.80
Oct 25, 2012	van plew daniel p	Officer	Option Execute	30,000	21.92
Aug 4, 2011	van plew daniel p	Officer	Option Execute	4,784	20.90
Apr 27, 2012	van plew daniel p	Officer	Option Execute	35,216	20.90
Jan 18, 2011	van plew daniel p	Officer	Option Execute	25,000	20.90 - 21.92
Dec 16, 2010	van plew daniel p	Officer	Option Execute	25,000	20.90
May 6, 2013	van plew daniel p	Officer	Option Execute	32,950	16.80
May 6, 2013	yancopoulos george	Officer	Option Execute	192,308	13.00
Dec 3, 2009	yancopoulos george	Officer	Option Execute	100,000	8.77
Dec 16, 2008	yancopoulos george	Officer	Option Execute	100,000	7.41
Feb 15, 2012	yancopoulos george	Officer	Option Execute	133,332	8.50
Showing 241-260 of 627 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.